Plasma p‐tau181 as a Marker of Conversion to Alzheimer's Disease Dementia and Worsening in Cognitive Functions in Subjective Cognitive Decline and Mild Cognitive Impairment: A Longitudinal Study

ABSTRACT Background Plasma p‐tau181 has proven to be a promising diagnostic and prognostic tool in the earliest phases of Alzheimer's disease (AD). We aimed to evaluate the prognostic role of p‐tau181 in predicting conversion to AD dementia and worsening in cognition in mild cognitive impairment (MC...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Giulia Giacomucci, Assunta Ingannato, Chiara Crucitti, Silvia Bagnoli, Elisa Marcantelli, Sonia Padiglioni, Valentina Moschini, Carmen Morinelli, Laura Falsini, Sandro Sorbi, Valentina Berti, Benedetta Nacmias, Valentina Bessi
Format:	Artigo
Język:	Inglês
Wydane:	Wiley 2025-12-01
Seria:	Annals of Clinical and Translational Neurology
Hasła przedmiotowe:	Alzheimer's disease cognitive worsening mild cognitive impairment plasma biomarkers plasma p‐tau181 subjective cognitive decline
Dostęp online:	https://doi.org/10.1002/acn3.70190
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!